United States Botulism Illness Market Report 2017

November 2017 | 113 pages | ID: U2F6723EA07WEN
QYResearch

Abstracts

In this report, the United States Botulism Illness market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Botulism Illness in these regions, from 2012 to 2022 (forecast).

United States Botulism Illness market competition by top manufacturers/players, with Botulism Illness sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• MerckMillipore
• Sigma Aldrich
• Fisher Scientific
• Otsuka Chemical Co Ltd
• MerckMillipore
• Loba Chemie
• Lenntech
• Arkema SA
• Bann Quimica
• Chemtura Corporation
• Behn Meyer Solutia Incorporated
• Emerald Performance Materials
• Lanxess AG
• Eastman Chemicals Co

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Antibiotics
• Antitoxins
• Trivalent
• Heptavalent

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Botulism Illness for each application, including

• Hospitals
• Pharmacies
• Clinics
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Botulism Illness Market Report 2017

1 BOTULISM ILLNESS OVERVIEW

1.1 Product Overview and Scope of Botulism Illness
1.2 Classification of Botulism Illness by Product Category
  1.2.1 United States Botulism Illness Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Botulism Illness Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Antibiotics
  1.2.4 Antitoxins
  1.2.5 Trivalent
  1.2.6 Heptavalent
1.3 United States Botulism Illness Market by Application/End Users
  1.3.1 United States Botulism Illness Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Pharmacies
  1.3.4 Clinics
  1.3.5 Others
1.4 United States Botulism Illness Market by Region
  1.4.1 United States Botulism Illness Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Botulism Illness Status and Prospect (2012-2022)
  1.4.3 Southwest Botulism Illness Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Botulism Illness Status and Prospect (2012-2022)
  1.4.5 New England Botulism Illness Status and Prospect (2012-2022)
  1.4.6 The South Botulism Illness Status and Prospect (2012-2022)
  1.4.7 The Midwest Botulism Illness Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Botulism Illness (2012-2022)
  1.5.1 United States Botulism Illness Sales and Growth Rate (2012-2022)
  1.5.2 United States Botulism Illness Revenue and Growth Rate (2012-2022)

2 UNITED STATES BOTULISM ILLNESS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Botulism Illness Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Botulism Illness Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Botulism Illness Average Price by Players/Suppliers (2012-2017)
2.4 United States Botulism Illness Market Competitive Situation and Trends
  2.4.1 United States Botulism Illness Market Concentration Rate
  2.4.2 United States Botulism Illness Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Botulism Illness Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES BOTULISM ILLNESS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Botulism Illness Sales and Market Share by Region (2012-2017)
3.2 United States Botulism Illness Revenue and Market Share by Region (2012-2017)
3.3 United States Botulism Illness Price by Region (2012-2017)

4 UNITED STATES BOTULISM ILLNESS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Botulism Illness Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Botulism Illness Revenue and Market Share by Type (2012-2017)
4.3 United States Botulism Illness Price by Type (2012-2017)
4.4 United States Botulism Illness Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BOTULISM ILLNESS SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Botulism Illness Sales and Market Share by Application (2012-2017)
5.2 United States Botulism Illness Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BOTULISM ILLNESS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 MerckMillipore
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Botulism Illness Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 MerckMillipore Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sigma Aldrich
  6.2.2 Botulism Illness Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sigma Aldrich Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Fisher Scientific
  6.3.2 Botulism Illness Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Fisher Scientific Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Otsuka Chemical Co Ltd
  6.4.2 Botulism Illness Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Otsuka Chemical Co Ltd Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 MerckMillipore
  6.5.2 Botulism Illness Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 MerckMillipore Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Loba Chemie
  6.6.2 Botulism Illness Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Loba Chemie Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Lenntech
  6.7.2 Botulism Illness Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Lenntech Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Arkema SA
  6.8.2 Botulism Illness Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Arkema SA Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Bann Quimica
  6.9.2 Botulism Illness Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Bann Quimica Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Chemtura Corporation
  6.10.2 Botulism Illness Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Chemtura Corporation Botulism Illness Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Behn Meyer Solutia Incorporated
6.12 Emerald Performance Materials
6.13 Lanxess AG
6.14 Eastman Chemicals Co

7 BOTULISM ILLNESS MANUFACTURING COST ANALYSIS

7.1 Botulism Illness Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Botulism Illness

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Botulism Illness Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Botulism Illness Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BOTULISM ILLNESS MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Botulism Illness Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Botulism Illness Sales Volume Forecast by Type (2017-2022)
11.3 United States Botulism Illness Sales Volume Forecast by Application (2017-2022)
11.4 United States Botulism Illness Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Botulism Illness
Figure United States Botulism Illness Market Size (K Units) by Type (2012-2022)
Figure United States Botulism Illness Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibiotics Product Picture
Figure Antitoxins Product Picture
Figure Trivalent Product Picture
Figure Heptavalent Product Picture
Figure United States Botulism Illness Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Botulism Illness by Application in 2016
Figure Hospitals Examples
Table Key Downstream Customer in Hospitals
Figure Pharmacies Examples
Table Key Downstream Customer in Pharmacies
Figure Clinics Examples
Table Key Downstream Customer in Clinics
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Botulism Illness Market Size (Million USD) by Region (2012-2022)
Figure The West Botulism Illness Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Botulism Illness Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Botulism Illness Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Botulism Illness Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Botulism Illness Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Botulism Illness Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Botulism Illness Sales (K Units) and Growth Rate (2012-2022)
Figure United States Botulism Illness Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Botulism Illness Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Botulism Illness Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Botulism Illness Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Botulism Illness Sales Share by Players/Suppliers
Figure 2017 United States Botulism Illness Sales Share by Players/Suppliers
Figure United States Botulism Illness Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Botulism Illness Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Botulism Illness Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Botulism Illness Revenue Share by Players/Suppliers
Figure 2017 United States Botulism Illness Revenue Share by Players/Suppliers
Table United States Market Botulism Illness Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Botulism Illness Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Botulism Illness Market Share of Top 3 Players/Suppliers
Figure United States Botulism Illness Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Botulism Illness Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Botulism Illness Product Category
Table United States Botulism Illness Sales (K Units) by Region (2012-2017)
Table United States Botulism Illness Sales Share by Region (2012-2017)
Figure United States Botulism Illness Sales Share by Region (2012-2017)
Figure United States Botulism Illness Sales Market Share by Region in 2016
Table United States Botulism Illness Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Botulism Illness Revenue Share by Region (2012-2017)
Figure United States Botulism Illness Revenue Market Share by Region (2012-2017)
Figure United States Botulism Illness Revenue Market Share by Region in 2016
Table United States Botulism Illness Price (USD/Unit) by Region (2012-2017)
Table United States Botulism Illness Sales (K Units) by Type (2012-2017)
Table United States Botulism Illness Sales Share by Type (2012-2017)
Figure United States Botulism Illness Sales Share by Type (2012-2017)
Figure United States Botulism Illness Sales Market Share by Type in 2016
Table United States Botulism Illness Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Botulism Illness Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Botulism Illness by Type (2012-2017)
Figure Revenue Market Share of Botulism Illness by Type in 2016
Table United States Botulism Illness Price (USD/Unit) by Types (2012-2017)
Figure United States Botulism Illness Sales Growth Rate by Type (2012-2017)
Table United States Botulism Illness Sales (K Units) by Application (2012-2017)
Table United States Botulism Illness Sales Market Share by Application (2012-2017)
Figure United States Botulism Illness Sales Market Share by Application (2012-2017)
Figure United States Botulism Illness Sales Market Share by Application in 2016
Table United States Botulism Illness Sales Growth Rate by Application (2012-2017)
Figure United States Botulism Illness Sales Growth Rate by Application (2012-2017)
Table MerckMillipore Basic Information List
Table MerckMillipore Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MerckMillipore Botulism Illness Sales Growth Rate (2012-2017)
Figure MerckMillipore Botulism Illness Sales Market Share in United States (2012-2017)
Figure MerckMillipore Botulism Illness Revenue Market Share in United States (2012-2017)
Table Sigma Aldrich Basic Information List
Table Sigma Aldrich Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sigma Aldrich Botulism Illness Sales Growth Rate (2012-2017)
Figure Sigma Aldrich Botulism Illness Sales Market Share in United States (2012-2017)
Figure Sigma Aldrich Botulism Illness Revenue Market Share in United States (2012-2017)
Table Fisher Scientific Basic Information List
Table Fisher Scientific Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Fisher Scientific Botulism Illness Sales Growth Rate (2012-2017)
Figure Fisher Scientific Botulism Illness Sales Market Share in United States (2012-2017)
Figure Fisher Scientific Botulism Illness Revenue Market Share in United States (2012-2017)
Table Otsuka Chemical Co Ltd Basic Information List
Table Otsuka Chemical Co Ltd Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Otsuka Chemical Co Ltd Botulism Illness Sales Growth Rate (2012-2017)
Figure Otsuka Chemical Co Ltd Botulism Illness Sales Market Share in United States (2012-2017)
Figure Otsuka Chemical Co Ltd Botulism Illness Revenue Market Share in United States (2012-2017)
Table MerckMillipore Basic Information List
Table MerckMillipore Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure MerckMillipore Botulism Illness Sales Growth Rate (2012-2017)
Figure MerckMillipore Botulism Illness Sales Market Share in United States (2012-2017)
Figure MerckMillipore Botulism Illness Revenue Market Share in United States (2012-2017)
Table Loba Chemie Basic Information List
Table Loba Chemie Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Loba Chemie Botulism Illness Sales Growth Rate (2012-2017)
Figure Loba Chemie Botulism Illness Sales Market Share in United States (2012-2017)
Figure Loba Chemie Botulism Illness Revenue Market Share in United States (2012-2017)
Table Lenntech Basic Information List
Table Lenntech Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Lenntech Botulism Illness Sales Growth Rate (2012-2017)
Figure Lenntech Botulism Illness Sales Market Share in United States (2012-2017)
Figure Lenntech Botulism Illness Revenue Market Share in United States (2012-2017)
Table Arkema SA Basic Information List
Table Arkema SA Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Arkema SA Botulism Illness Sales Growth Rate (2012-2017)
Figure Arkema SA Botulism Illness Sales Market Share in United States (2012-2017)
Figure Arkema SA Botulism Illness Revenue Market Share in United States (2012-2017)
Table Bann Quimica Basic Information List
Table Bann Quimica Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bann Quimica Botulism Illness Sales Growth Rate (2012-2017)
Figure Bann Quimica Botulism Illness Sales Market Share in United States (2012-2017)
Figure Bann Quimica Botulism Illness Revenue Market Share in United States (2012-2017)
Table Chemtura Corporation Basic Information List
Table Chemtura Corporation Botulism Illness Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Chemtura Corporation Botulism Illness Sales Growth Rate (2012-2017)
Figure Chemtura Corporation Botulism Illness Sales Market Share in United States (2012-2017)
Figure Chemtura Corporation Botulism Illness Revenue Market Share in United States (2012-2017)
Table Behn Meyer Solutia Incorporated Basic Information List
Table Emerald Performance Materials Basic Information List
Table Lanxess AG Basic Information List
Table Eastman Chemicals Co Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Botulism Illness
Figure Manufacturing Process Analysis of Botulism Illness
Figure Botulism Illness Industrial Chain Analysis
Table Raw Materials Sources of Botulism Illness Major Players/Suppliers in 2016
Table Major Buyers of Botulism Illness
Table Distributors/Traders List
Figure United States Botulism Illness Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Botulism Illness Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Botulism Illness Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Botulism Illness Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Botulism Illness Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Botulism Illness Sales Volume (K Units) Forecast by Type in 2022
Table United States Botulism Illness Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Botulism Illness Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Botulism Illness Sales Volume (K Units) Forecast by Application in 2022
Table United States Botulism Illness Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Botulism Illness Sales Volume Share Forecast by Region (2017-2022)
Figure United States Botulism Illness Sales Volume Share Forecast by Region (2017-2022)
Figure United States Botulism Illness Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources